At a glance
ClinicalIndex Comparison RecordN/ACompleted· 490 enrolled
Drug / intervention
immunosuppressantdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development and Validation of a Nomogram for Predicting Surgery in Newly-diagnosed Crohn's Disease: a Retrospective Cohort Study
First Affiliated Hospital, Sun Yat-Sen University·observational·Posted Jun 13, 2024·Updated Jun 13, 2024
In Brief
An observational study evaluating immunosuppressant for Newly-diagnosed Crohn's Disease. Completed, enrolled 490 participants.
Detailed Summary
A majority of patients with Crohn's disease undergo surgery during the disease course. We aimed to develop an easily available nomogram to predict the risk of surgery at diagnosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNewly-diagnosed Crohn's Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2005
Primary CompletionDec 2022
Study CompletionDec 2023
First PostedJun 2024
TodayJul 2026
First PostedJun 13, 2024
Enrollment StartJan 1, 2005
Primary CompletionDec 31, 2022
Study CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 18 yearsPosted 2.1 years ago
Interventions
immunosuppressantdrug
No intervention was performed in this retrospective cohort study.